ment dates that could move the market: 5 July, Barry Callebaut; 12 July, Partners Group; 16 July, Kuhne+Nagel; 17 July, Georg Fischer & SGS; 19 July, Actelion; 20 July, Sulzer; 25 July, Rieter & Lonza; 26 July, ABB, CS Group, Logitech & Sika 36 UBS For further information please contact CIO's asset class

Q42014 33 EFTA00506102 Epiphany has a very experienced team • Fred Volirtsky, MD, Founder, Chairman & CEO . Co-founded Colherix (acquired by Actelion for S430m); member Ballard Life Science Fund LAB • Previously Managing Director at ACT BioYentures • Held Directorships at Myornetrix,Ckterie Pha